Enanta Pharmaceuticals Inc
NASDAQ:ENTA
Income Statement
Earnings Waterfall
Enanta Pharmaceuticals Inc
Revenue
|
73.6m
USD
|
Operating Expenses
|
-215.7m
USD
|
Operating Income
|
-142.1m
USD
|
Other Expenses
|
3.8m
USD
|
Net Income
|
-138.2m
USD
|
Income Statement
Enanta Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
5
N/A
|
6
+19%
|
46
+668%
|
48
+3%
|
124
+161%
|
180
+44%
|
149
-17%
|
161
+8%
|
132
-18%
|
87
-34%
|
90
+3%
|
88
-2%
|
50
-43%
|
46
-8%
|
40
-14%
|
103
+159%
|
131
+27%
|
166
+27%
|
215
+30%
|
207
-4%
|
238
+15%
|
234
-2%
|
221
-6%
|
205
-7%
|
188
-8%
|
176
-6%
|
150
-15%
|
123
-18%
|
102
-17%
|
94
-7%
|
97
+3%
|
97
0%
|
93
-4%
|
92
-2%
|
89
-2%
|
86
-4%
|
82
-5%
|
81
-1%
|
81
-1%
|
79
-2%
|
74
-7%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(23)
|
(26)
|
(27)
|
(29)
|
(30)
|
(31)
|
(34)
|
(37)
|
(42)
|
(47)
|
(52)
|
(57)
|
(62)
|
(67)
|
(73)
|
(78)
|
(84)
|
(93)
|
(107)
|
(118)
|
(137)
|
(150)
|
(156)
|
(169)
|
(166)
|
(165)
|
(166)
|
(164)
|
(168)
|
(179)
|
(193)
|
(207)
|
(221)
|
(223)
|
(220)
|
(210)
|
(206)
|
(210)
|
(214)
|
(216)
|
(216)
|
|
Selling, General & Administrative |
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(12)
|
(13)
|
(14)
|
(15)
|
(16)
|
(16)
|
(17)
|
(18)
|
(19)
|
(20)
|
(21)
|
(22)
|
(22)
|
(23)
|
(23)
|
(25)
|
(26)
|
(26)
|
(26)
|
(26)
|
(26)
|
(27)
|
(27)
|
(28)
|
(29)
|
(31)
|
(33)
|
(35)
|
(37)
|
(41)
|
(46)
|
(49)
|
(52)
|
(52)
|
(53)
|
(57)
|
|
Research & Development |
(16)
|
(17)
|
(18)
|
(19)
|
(19)
|
(20)
|
(21)
|
(23)
|
(28)
|
(31)
|
(36)
|
(41)
|
(44)
|
(48)
|
(52)
|
(58)
|
(63)
|
(71)
|
(84)
|
(95)
|
(112)
|
(124)
|
(130)
|
(142)
|
(140)
|
(139)
|
(139)
|
(137)
|
(141)
|
(150)
|
(162)
|
(174)
|
(186)
|
(187)
|
(179)
|
(165)
|
(157)
|
(158)
|
(162)
|
(164)
|
(159)
|
|
Operating Income |
(18)
N/A
|
(19)
-6%
|
20
N/A
|
19
-3%
|
95
+398%
|
148
+57%
|
115
-22%
|
124
+8%
|
90
-28%
|
40
-55%
|
38
-7%
|
31
-18%
|
(12)
N/A
|
(21)
-76%
|
(33)
-58%
|
25
N/A
|
46
+87%
|
72
+57%
|
108
+49%
|
88
-18%
|
102
+15%
|
84
-18%
|
65
-23%
|
37
-43%
|
22
-41%
|
11
-49%
|
(15)
N/A
|
(42)
-170%
|
(67)
-61%
|
(85)
-27%
|
(96)
-13%
|
(110)
-15%
|
(128)
-17%
|
(132)
-3%
|
(131)
+1%
|
(124)
+5%
|
(123)
+0%
|
(129)
-5%
|
(133)
-3%
|
(137)
-3%
|
(142)
-4%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
9
|
9
|
8
|
7
|
5
|
4
|
3
|
2
|
2
|
1
|
1
|
2
|
2
|
4
|
5
|
6
|
6
|
|
Pre-Tax Income |
(18)
N/A
|
(19)
-8%
|
20
N/A
|
19
-3%
|
95
+393%
|
149
+57%
|
116
-22%
|
126
+8%
|
91
-28%
|
42
-54%
|
39
-6%
|
33
-17%
|
(10)
N/A
|
(19)
-90%
|
(31)
-63%
|
27
N/A
|
49
+81%
|
76
+55%
|
112
+48%
|
93
-17%
|
108
+15%
|
91
-16%
|
73
-20%
|
46
-37%
|
31
-33%
|
20
-35%
|
(8)
N/A
|
(35)
-356%
|
(62)
-76%
|
(81)
-31%
|
(93)
-15%
|
(108)
-16%
|
(126)
-17%
|
(131)
-4%
|
(129)
+1%
|
(122)
+5%
|
(121)
+1%
|
(125)
-3%
|
(128)
-2%
|
(131)
-3%
|
(136)
-4%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
15
|
15
|
(13)
|
(33)
|
(48)
|
(47)
|
(28)
|
(9)
|
(10)
|
(11)
|
0
|
6
|
10
|
(9)
|
(11)
|
(20)
|
(27)
|
(17)
|
(21)
|
(13)
|
(8)
|
1
|
3
|
4
|
10
|
(1)
|
4
|
7
|
9
|
29
|
25
|
18
|
9
|
0
|
0
|
0
|
(4)
|
(3)
|
(2)
|
|
Income from Continuing Operations |
(18)
|
(19)
|
35
|
34
|
82
|
116
|
68
|
79
|
63
|
33
|
29
|
22
|
(10)
|
(13)
|
(21)
|
18
|
38
|
56
|
85
|
76
|
86
|
78
|
65
|
46
|
34
|
24
|
2
|
(36)
|
(58)
|
(74)
|
(84)
|
(79)
|
(101)
|
(112)
|
(120)
|
(122)
|
(121)
|
(125)
|
(132)
|
(134)
|
(138)
|
|
Net Income (Common) |
(14)
N/A
|
(14)
-2%
|
40
N/A
|
34
-14%
|
82
+138%
|
116
+41%
|
68
-41%
|
79
+16%
|
63
-20%
|
33
-48%
|
29
-11%
|
22
-26%
|
(10)
N/A
|
(13)
-39%
|
(21)
-55%
|
18
N/A
|
34
+94%
|
52
+52%
|
81
+55%
|
72
-11%
|
86
+20%
|
78
-10%
|
65
-17%
|
46
-28%
|
34
-27%
|
24
-30%
|
2
-90%
|
(36)
N/A
|
(58)
-60%
|
(74)
-28%
|
(84)
-13%
|
(79)
+6%
|
(101)
-28%
|
(112)
-11%
|
(120)
-7%
|
(122)
-1%
|
(121)
+1%
|
(125)
-3%
|
(132)
-6%
|
(134)
-1%
|
(138)
-3%
|
|
EPS (Diluted) |
-0.76
N/A
|
-0.77
-1%
|
2.09
N/A
|
1.8
-14%
|
4.24
+136%
|
6.01
+42%
|
3.53
-41%
|
4.09
+16%
|
3.28
-20%
|
1.73
-47%
|
1.54
-11%
|
1.13
-27%
|
-0.5
N/A
|
-0.69
-38%
|
-1.07
-55%
|
0.91
N/A
|
1.72
+89%
|
2.54
+48%
|
3.85
+52%
|
3.47
-10%
|
4.13
+19%
|
3.69
-11%
|
3.08
-17%
|
2.21
-28%
|
1.62
-27%
|
1.18
-27%
|
0.11
-91%
|
-1.81
N/A
|
-2.88
-59%
|
-3.67
-27%
|
-4.15
-13%
|
-3.92
+6%
|
-4.94
-26%
|
-5.46
-11%
|
-5.79
-6%
|
-5.91
-2%
|
-5.79
+2%
|
-5.92
-2%
|
-6.27
-6%
|
-6.38
-2%
|
-6.56
-3%
|